Clinical Trial

Primary ACL Reconstruction in Patient Over 40 Years: Allograft Versus Autograft

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 5, 2024 (before its estimated January 2025 completion). Its status may not reflect the trial's current state.
Summary
The aim of this study is to investigate the differences in graft failure between patients that underwent ACL reconstruction using allograft tendons and patients that underwent ACL reconstruction using autograft tendons in patients older than 40 y.o. and after at least 2 years of follow-up. The hypothesis of the study is that there will be a difference in graft failure and patient reported functional outcomes between allograft and autograft ACL reconstruction.
Trial Details
NCT Number NCT06584838
Lead Sponsor Università Vita-Salute San Raffaele
Conditions ACL, ACL Injury
Enrollment 40 participants
Start Date 2024-12
Primary Completion 2025-01 (estimated)
Study Completion 2025-02 (estimated)
Updated on ClinicalTrials.gov 2024-09-05